UK's CVS Group H1 revenue up 5.8%,

CVS

26/02/2026 07:12

Overview

UK veterinary services provider's H1 2026 revenue rose 5.8% yr/yr

Adjusted EBITDA for H1 2026 missed analyst expectations

Company expanded Australian operations with acquisitions and practice investments

Outlook

CVS sees attractive growth opportunities in Australia with ongoing acquisitions

Company remains confident in delivering FY2026 results in line with market expectations

CVS expects CMA's final decision in Spring 2026, engaging on proposed remedies

Result Drivers

AUSTRALIA EXPANSION - Strategic expansion in Australia with acquisitions and practice investments contributed to revenue growth

INVESTMENT IN FACILITIES - £17.5m invested in practice relocations, refurbishments, and clinical equipment to enhance capacity and client experience

COST EFFICIENCIES - Maintained margins despite wage inflation and increased national insurance costs through cost efficiencies

Company press release: ID:nRSZ4391Ua

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
H1 Adjusted EBITDA
Miss
GBP 67.70 mln
GBP 69.90 mln (1 Analyst)
H1 Adjusted Pretax Profit
Miss
GBP 40.30 mln
GBP 42.90 mln (1 Analyst)
H1 Adjusted EBITDA Margin
19.00%
H1 Basic EPS
GBP 0.11
H1 EBIT
GBP 22.10 mln
H1 Pretax Profit
GBP 15.20 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for CVS Group PLC is GBp1,650.00, about 20.4% above its February 25 closing price of GBp1,370.00

The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 13 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)